Screener · short volume
Short volume screener
Screen US-listed companies by FINRA daily short volume. Filter by market cap, sector, and industry, and sort by short %, short volume, total volume, or market cap.
1D · FINRA Reg SHO · as of Jun 12, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | MPLT | MapLight Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.26B | 142.2K | 156.4K | 90.9% |
| 2 | APGE | Apogee Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $6.66B | 221.6K | 245.9K | 90.1% |
| 3 | AURA | Aura Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $662.7M | 404.2K | 453.3K | 89.2% |
| 4 | DYN | Dyne Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.01B | 277.6K | 319.6K | 86.8% |
| 5 | MANE | Veradermics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $4.01B | 95.6K | 112.2K | 85.2% |
| 6 | CGON | CG Oncology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $5.25B | 253.9K | 299.3K | 84.8% |
| 7 | CRL | Charles River Laboratories International Inc. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $9.03B | 144.1K | 172.9K | 83.4% |
| 8 | KYMR | Kymera Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $7.09B | 200.2K | 245.2K | 81.7% |
| 9 | IART | Integra LifeSciences Holdings Corporation | Health CareMedical/Dental Instruments | $1.38B | 139.5K | 171.2K | 81.5% |
| 10 | BEAM | Beam Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $2.99B | 459.7K | 571.8K | 80.4% |
| 11 | GKOS | Glaukos Corporation | Health CareMedical/Dental Instruments | $7.45B | 191.5K | 241.2K | 79.4% |
| 12 | PRKS | United Parks & Resorts Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $2.16B | 203.5K | 256.4K | 79.4% |
| 13 | SABS | SAB Biotherapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $254.6M | 176.6K | 222.5K | 79.3% |
| 14 | ANAB | AnaptysBio Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.63B | 144.4K | 182.9K | 78.9% |
| 15 | AKTS | Aktis Oncology Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.21B | 322.9K | 409.4K | 78.9% |
| 16 | IDYA | IDEAYA Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.55B | 183.5K | 232.8K | 78.8% |
| 17 | MEDP | Medpace Holdings Inc. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $13.35B | 92.9K | 118.3K | 78.5% |
| 18 | EIKN | Eikon Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $473.7M | 79.4K | 101.4K | 78.3% |
| 19 | RMD | ResMed Inc. | Health CareMedical/Dental Instruments | $28.25B | 396.1K | 513.9K | 77.1% |
| 20 | LXEO | Lexeo Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $343.1M | 166.5K | 216.2K | 77.0% |
| 21 | ZLAB | Zai Lab Limited | Health CareBiotechnology: Pharmaceutical Preparations | $1.92B | 343.5K | 446.3K | 77.0% |
| 22 | XNCR | Xencor Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $914.2M | 122.4K | 160.9K | 76.0% |
| 23 | STOK | Stoke Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.86B | 154.4K | 203.2K | 76.0% |
| 24 | CORT | Corcept Therapeutics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $8.90B | 209.7K | 276.0K | 76.0% |
| 25 | PTCT | PTC Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.23B | 298.8K | 394.2K | 75.8% |
| 26 | KALV | KalVista Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.44B | 366.4K | 485.4K | 75.5% |
| 27 | BAX | Baxter International Inc. | Health CareMedical/Dental Instruments | $10.77B | 2.00M | 2.65M | 75.4% |
| 28 | ZBH | Zimmer Biomet Holdings Inc. | Health CareIndustrial Specialties | $17.13B | 452.3K | 600.3K | 75.3% |
| 29 | CATX | Perspective Therapeutics Inc. | Health CareMedical/Dental Instruments | $336.4M | 307.9K | 413.6K | 74.4% |
| 30 | EQ | Equillium Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $177.7M | 169.5K | 227.7K | 74.4% |
| 31 | ELAN | Elanco Animal Health Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $12.07B | 1.23M | 1.66M | 74.2% |
| 32 | TRAX | First Tracks Biotherapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $615.5M | 122.4K | 165.0K | 74.2% |
| 33 | GANX | Gain Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $71.7M | 206.7K | 279.0K | 74.1% |
| 34 | NEO | NeoGenomics Inc. | Health CarePrecision Instruments | $1.45B | 402.4K | 544.9K | 73.9% |
| 35 | PGNY | Progyny Inc. | Health CareMisc Health and Biotechnology Services | $2.09B | 255.1K | 346.6K | 73.6% |
| 36 | FDMT | 4D Molecular Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $461.6M | 113.3K | 154.1K | 73.5% |
| 37 | ORKA | Oruka Therapeutics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $4.22B | 182.5K | 248.8K | 73.3% |
| 38 | TAK | Takeda Pharmaceutical Company Limited | Health CareBiotechnology: Pharmaceutical Preparations | $50.07B | 1.13M | 1.54M | 73.2% |
| 39 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.55B | 1.18M | 1.61M | 73.2% |
| 40 | CNTN | Canton Strategic Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $215.7M | 237.3K | 324.8K | 73.1% |
| 41 | GRAL | GRAIL Inc. | Health CareMedical Specialities | $2.57B | 90.4K | 124.2K | 72.8% |
| 42 | GLUE | Monte Rosa Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.54B | 373.0K | 513.2K | 72.7% |
| 43 | IKT | Inhibikase Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $220.5M | 176.3K | 244.3K | 72.1% |
| 44 | KRYS | Krystal Biotech Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $9.37B | 86.8K | 121.5K | 71.5% |
| 45 | MO | Altria Group Inc. | Health Care Medicinal Chemicals and Botanical Products | $120.13B | 1.74M | 2.44M | 71.4% |
| 46 | EDIT | Editas Medicine Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $244.8M | 592.3K | 830.2K | 71.3% |
| 47 | TECH | Bio-Techne Corp | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $8.45B | 438.4K | 615.4K | 71.2% |
| 48 | JAZZ | Jazz Pharmaceuticals plc | Health CareBiotechnology: Pharmaceutical Preparations | $14.48B | 216.2K | 303.9K | 71.2% |
| 49 | KPTI | Karyopharm Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $215.3M | 200.5K | 282.3K | 71.0% |
| 50 | CAH | Cardinal Health Inc. | Health CareOther Pharmaceuticals | $52.43B | 641.5K | 910.6K | 70.4% |
| 51 | BIIB | Biogen Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $29.53B | 246.2K | 349.6K | 70.4% |
| 52 | DSGN | Design Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $685.2M | 89.3K | 126.9K | 70.4% |
| 53 | STIM | Neuronetics Inc. | Health CareMedical/Dental Instruments | $92.6M | 401.3K | 574.3K | 69.9% |
| 54 | ESTA | Establishment Labs Holdings Inc. | Health CareIndustrial Specialties | $2.42B | 154.9K | 221.6K | 69.9% |
| 55 | NRIX | Nurix Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.75B | 724.0K | 1.04M | 69.8% |
| 56 | INCY | Incyte Corp. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $21.68B | 421.0K | 603.0K | 69.8% |
| 57 | INDV | Indivior Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.80B | 151.4K | 218.1K | 69.4% |
| 58 | FMS | Fresenius Medical Care AG | Health CareMisc Health and Biotechnology Services | $12.86B | 74.2K | 107.1K | 69.4% |
| 59 | CYTK | Cytokinetics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $8.73B | 334.5K | 485.0K | 69.0% |
| 60 | RARE | Ultragenyx Pharmaceutical Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.40B | 448.2K | 650.4K | 68.9% |
| 61 | MAZE | Maze Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.33B | 164.4K | 238.7K | 68.9% |
| 62 | SGRY | Surgery Partners Inc. | Health CareHospital/Nursing Management | $2.00B | 239.5K | 348.7K | 68.7% |
| 63 | MIRM | Mirum Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.06B | 209.3K | 304.9K | 68.7% |
| 64 | DOMH | Dominari Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $71.5M | 79.5K | 115.9K | 68.6% |
| 65 | LMRI | Lumexa Imaging Holdings Inc. | Health CareMedical Specialities | $926.2M | 140.4K | 205.0K | 68.5% |
| 66 | AVTX | Avalo Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $775.9M | 300.6K | 440.1K | 68.3% |
| 67 | RLAY | Relay Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $2.84B | 412.7K | 605.0K | 68.2% |
| 68 | PRCT | PROCEPT BioRobotics Corporation | Health CareMedical/Dental Instruments | $1.46B | 325.8K | 478.9K | 68.0% |
| 69 | BLLN | BillionToOne Inc. | Health CareMedical Specialities | $4.65B | 164.5K | 242.1K | 67.9% |
| 70 | GENB | Generate Biomedicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.59B | 170.2K | 250.6K | 67.9% |
| 71 | LGND | Ligand Pharmaceuticals Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $5.12B | 75.6K | 111.4K | 67.9% |
| 72 | GNTA | Genenta Science S.p.A. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $90.2M | 91.4K | 134.8K | 67.8% |
| 73 | MDLN | Medline Inc. | Health CareMedical/Dental Instruments | $48.09B | 3.56M | 5.25M | 67.8% |
| 74 | HIMS | Hims & Hers Health Inc. | Health CareMedical/Nursing Services | $6.21B | 5.56M | 8.21M | 67.7% |
| 75 | SHC | Sotera Health Company | Health CareMisc Health and Biotechnology Services | $4.62B | 308.0K | 454.8K | 67.7% |
| 76 | CRSP | CRISPR Therapeutics AG | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $4.80B | 337.4K | 499.3K | 67.6% |
| 77 | ARDT | Ardent Health Inc. | Health CareHospital/Nursing Management | $1.34B | 130.6K | 193.3K | 67.6% |
| 78 | QDEL | QuidelOrtho Corporation | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $963.5M | 300.7K | 445.4K | 67.5% |
| 79 | MASI | Masimo Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $9.42B | 326.1K | 483.2K | 67.5% |
| 80 | ALC | Alcon Inc. | Health CareOphthalmic Goods | $33.40B | 269.7K | 401.0K | 67.3% |
| 81 | DVA | DaVita Inc. | Health CareMisc Health and Biotechnology Services | $13.40B | 245.9K | 367.1K | 67.0% |
| 82 | MIST | Milestone Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $158.1M | 310.0K | 464.5K | 66.7% |
| 83 | MD | Pediatrix Medical Group Inc. | Health CareHospital/Nursing Management | $2.00B | 105.0K | 157.4K | 66.7% |
| 84 | EYE | National Vision Holdings Inc. | Health CareOphthalmic Goods | $1.49B | 403.2K | 605.8K | 66.5% |
| 85 | LH | Labcorp Holdings Inc. | Health CareMedical Specialities | $21.83B | 105.8K | 159.1K | 66.5% |
| 86 | UHS | Universal Health Services Inc. | Health CareHospital/Nursing Management | $8.86B | 139.2K | 210.5K | 66.1% |
| 87 | RYTM | Rhythm Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.06B | 176.3K | 266.7K | 66.1% |
| 88 | SYK | Stryker Corporation | Health CareMedical/Dental Instruments | $119.69B | 977.5K | 1.48M | 65.9% |
| 89 | LIVN | LivaNova PLC | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $4.36B | 180.1K | 273.5K | 65.9% |
| 90 | MOH | Molina Healthcare Inc | Health CareMedical Specialities | $10.43B | 353.8K | 537.9K | 65.8% |
| 91 | ARGX | argenx SE | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $55.45B | 78.8K | 119.9K | 65.7% |
| 92 | QGEN | Qiagen N.V. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $7.64B | 428.4K | 654.4K | 65.5% |
| 93 | BMRN | BioMarin Pharmaceutical Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $10.81B | 252.5K | 387.1K | 65.2% |
| 94 | HCA | HCA Healthcare Inc. | Health CareHospital/Nursing Management | $85.89B | 442.0K | 678.6K | 65.1% |
| 95 | HUM | Humana Inc. | Health CareMedical Specialities | $45.53B | 247.7K | 380.8K | 65.0% |
| 96 | VOR | Vor Biopharma Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $778.1M | 138.5K | 213.1K | 65.0% |
| 97 | TLSI | TriSalus Life Sciences Inc. | Health CareMedical Specialities | $231.5M | 99.0K | 152.4K | 64.9% |
| 98 | CGTX | Cognition Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $108.3M | 179.2K | 276.6K | 64.8% |
| 99 | ONC | BeOne Medicines Ltd. | Health CareBiotechnology: Pharmaceutical Preparations | $29.40B | 73.2K | 113.2K | 64.7% |
| 100 | ALMS | Alumis Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.08B | 564.3K | 874.2K | 64.6% |